|
|
blood circulation
|
GO:0008015 |
195 |
0.660
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.478
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.463
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.449
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.408
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.407
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.400
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.369
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.330
|
|
|
|
positive regulation of lens epithelial cell proliferation
|
GO:2001111 |
1 |
0.329
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.303
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.257
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.249
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.232
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.230
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.229
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.222
|
|
|
|
cell migration involved in coronary angiogenesis
|
GO:0060981 |
1 |
0.217
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.216
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.209
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.208
|
|
|
|
smooth muscle cell chemotaxis
|
GO:0071670 |
2 |
0.197
|
|
|
|
cytokine secretion involved in immune response
|
GO:0002374 |
6 |
0.193
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.189
|
|
|
|
cellular response to erythropoietin
|
GO:0036018 |
1 |
0.185
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.181
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.180
|
|
|
|
detection of mechanical stimulus involved in equilibrioception
|
GO:0050973 |
2 |
0.178
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.175
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.169
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.167
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.161
|
|
|
|
regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:1900238 |
1 |
0.157
|
|
|
|
relaxation of smooth muscle
|
GO:0044557 |
8 |
0.153
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.150
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.150
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.147
|
|
|
|
response to heparin
|
GO:0071503 |
1 |
0.145
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.140
|
|
|
|
positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:0035793 |
1 |
0.136
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.133
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.127
|
|
|
|
vascular endothelial growth factor receptor signaling pathway
|
GO:0048010 |
24 |
0.125
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.125
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.120
|
|
|
|
regulation of cytokine secretion involved in immune response
|
GO:0002739 |
4 |
0.118
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.117
|
|
|
|
ascending aorta development
|
GO:0035905 |
3 |
0.116
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.111
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.111
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.111
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.110
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.110
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.109
|
|
|
|
relaxation of vascular smooth muscle
|
GO:0060087 |
7 |
0.108
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.107
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.104
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.104
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.103
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.101
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.101
|
|
|
|
regulation of vasculogenesis
|
GO:2001212 |
9 |
0.101
|
|
|
|
response to erythropoietin
|
GO:0036017 |
1 |
0.100
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.099
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.098
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.098
|
|
|
|
male germ line sex determination
|
GO:0019100 |
2 |
0.097
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.096
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.093
|
|
|
|
epithelial cell proliferation involved in prostatic bud elongation
|
GO:0060517 |
1 |
0.092
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.092
|
|
|
|
positive regulation of metanephric mesenchymal cell migration
|
GO:2000591 |
1 |
0.092
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.091
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.091
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.089
|
|
|
|
metanephric glomerulus morphogenesis
|
GO:0072275 |
3 |
0.087
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.087
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.087
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.086
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.085
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.085
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.085
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.085
|
|
|
|
cerebral cortex tangential migration using cell axon interactions
|
GO:0021824 |
3 |
0.084
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.083
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.083
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.083
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.082
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.081
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.081
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.080
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.079
|
|
|
|
soft palate development
|
GO:0060023 |
2 |
0.078
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.077
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.077
|
|
|
|
cardiac endothelial cell differentiation
|
GO:0003348 |
4 |
0.076
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.074
|
|
|
|
erythropoietin mediated signaling pathway
|
GO:0038162 |
1 |
0.074
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.074
|
|
|
|
negative regulation of muscle contraction
|
GO:0045932 |
12 |
0.073
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.071
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.071
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.070
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.069
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.069
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.069
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.069
|
|
|
|
endocardium formation
|
GO:0060214 |
4 |
0.068
|
|
|
|
intrahepatic bile duct development
|
GO:0035622 |
2 |
0.068
|
|
|
|
negative regulation of endothelial cell apoptotic process
|
GO:2000352 |
7 |
0.068
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.068
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.068
|
|
|
|
inner cell mass cellular morphogenesis
|
GO:0001828 |
1 |
0.067
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.067
|
|
|
|
regulation of lens epithelial cell proliferation
|
GO:2001109 |
1 |
0.066
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.066
|
|
|
|
cell migration involved in vasculogenesis
|
GO:0035441 |
2 |
0.066
|
|
|
|
metanephric glomerulus vasculature morphogenesis
|
GO:0072276 |
3 |
0.065
|
|
|
|
metanephric glomerular capillary formation
|
GO:0072277 |
3 |
0.065
|
|
|
|
neuronal action potential propagation
|
GO:0019227 |
8 |
0.064
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.064
|
|
|
|
positive regulation of cytokine secretion involved in immune response
|
GO:0002741 |
2 |
0.064
|
|
|
|
positive regulation of skeletal muscle tissue regeneration
|
GO:0043415 |
4 |
0.063
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.063
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.063
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.062
|
|
|
|
positive regulation of hippo signaling
|
GO:0035332 |
1 |
0.061
|
|
|
|
vegf activated neuropilin signaling pathway
|
GO:0038190 |
2 |
0.061
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.061
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.060
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.060
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.059
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.059
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.058
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.058
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.058
|
|
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.057
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.057
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
25 |
0.057
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.056
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.056
|
|
|
|
regulation of metanephric mesenchymal cell migration
|
GO:2000589 |
2 |
0.055
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.055
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.055
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.055
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.055
|
|
|
|
retina vasculature development in camera type eye
|
GO:0061298 |
17 |
0.055
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.054
|
|
|
|
regulation of cytokine production involved in immune response
|
GO:0002718 |
26 |
0.054
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.054
|
|
|
|
regulation of positive chemotaxis
|
GO:0050926 |
7 |
0.054
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.054
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.054
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.053
|
|
|
|
cardiogenic plate morphogenesis
|
GO:0003142 |
1 |
0.053
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.052
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.052
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.051
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.049
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.049
|
|
|
|
kidney vasculature development
|
GO:0061440 |
15 |
0.049
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.049
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.048
|
|
|
|
lung smooth muscle development
|
GO:0061145 |
2 |
0.048
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.048
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.047
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.047
|
|
|
|
termination of rna polymerase i transcription
|
GO:0006363 |
2 |
0.047
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.047
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.047
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.047
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.046
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.046
|
|
|
|
cellular response to heparin
|
GO:0071504 |
1 |
0.046
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.046
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.046
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.046
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.046
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.046
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.045
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.045
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.045
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.045
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.045
|
|
|
|
germ line sex determination
|
GO:0018992 |
3 |
0.044
|
|
|
|
regulation of stem cell division
|
GO:2000035 |
4 |
0.044
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.044
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.044
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.044
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.044
|
|
|
|
positive regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014718 |
2 |
0.043
|
|
|
|
pro t cell differentiation
|
GO:0002572 |
3 |
0.043
|
|
|
|
ruffle organization
|
GO:0031529 |
16 |
0.043
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.043
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.043
|
|
|
|
negative regulation of photoreceptor cell differentiation
|
GO:0046533 |
4 |
0.043
|
|
|
|
positive regulation of peptidyl serine phosphorylation
|
GO:0033138 |
25 |
0.043
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.042
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.042
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.042
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.042
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.042
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.042
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.042
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.041
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.041
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.041
|
|
|
|
cellular response to stem cell factor stimulus
|
GO:0036216 |
3 |
0.041
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.041
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.041
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.040
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.040
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.040
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.040
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.040
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.039
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.039
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.039
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.039
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.039
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.039
|
|
|
|
kit signaling pathway
|
GO:0038109 |
3 |
0.039
|
|
|
|
cellular response to epidermal growth factor stimulus
|
GO:0071364 |
4 |
0.039
|
|
|
|
regulation of smooth muscle contraction
|
GO:0006940 |
22 |
0.039
|
|
|
|
response to macrophage colony stimulating factor
|
GO:0036005 |
3 |
0.038
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.038
|
|
|
|
pigment cell differentiation
|
GO:0050931 |
27 |
0.038
|
|
|
|
atrial septum primum morphogenesis
|
GO:0003289 |
3 |
0.038
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.038
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.037
|
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.037
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.037
|
|
|
|
melanocyte migration
|
GO:0097324 |
2 |
0.037
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.037
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.037
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.036
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.036
|
|
|
|
positive regulation of extracellular matrix organization
|
GO:1903055 |
4 |
0.036
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.036
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.036
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.035
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.035
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.035
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.035
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.035
|
|
|
|
gall bladder development
|
GO:0061010 |
2 |
0.035
|
|
|
|
regulation of phosphatidylinositol 3 kinase activity
|
GO:0043551 |
14 |
0.034
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.034
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
20 |
0.034
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.034
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.033
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.033
|
|
|
|
detection of mechanical stimulus involved in sensory perception
|
GO:0050974 |
23 |
0.033
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.033
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.033
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.033
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.033
|
|
|
|
prostate gland morphogenetic growth
|
GO:0060737 |
4 |
0.033
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.032
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.032
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.032
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.032
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.032
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.032
|
|
|
|
ureter urothelium development
|
GO:0072190 |
3 |
0.032
|
|
|
|
regulation of cell proliferation involved in tissue homeostasis
|
GO:0060784 |
1 |
0.032
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.032
|
|
|
|
noradrenergic neuron differentiation
|
GO:0003357 |
6 |
0.031
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.031
|
|
|
|
endocardium development
|
GO:0003157 |
10 |
0.031
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.031
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.031
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.031
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.031
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.031
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.031
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.031
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.030
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.030
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.030
|
|
|
|
regulation of endothelial cell apoptotic process
|
GO:2000351 |
9 |
0.030
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.030
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.030
|
|
|
|
equilibrioception
|
GO:0050957 |
3 |
0.030
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.030
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.030
|
|
|
|
dendritic cell cytokine production
|
GO:0002371 |
3 |
0.030
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.030
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.029
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.029
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.029
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.029
|
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
18 |
0.029
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.029
|
|
|
|
detection of mechanical stimulus involved in sensory perception of sound
|
GO:0050910 |
16 |
0.029
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.029
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.028
|
|
|
|
lymph vessel morphogenesis
|
GO:0036303 |
11 |
0.028
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.028
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.028
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.028
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.028
|
|
|
|
angiogenesis involved in coronary vascular morphogenesis
|
GO:0060978 |
2 |
0.028
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.028
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.028
|
|
|
|
phosphatidylinositol metabolic process
|
GO:0046488 |
45 |
0.028
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.028
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.028
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.028
|
|
|
|
regulation of inward rectifier potassium channel activity
|
GO:1901979 |
1 |
0.028
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.027
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.027
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.027
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.027
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.027
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.026
|
|
|
|
sympathetic neuron projection extension
|
GO:0097490 |
4 |
0.026
|
|
|
|
pro b cell differentiation
|
GO:0002328 |
10 |
0.026
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.026
|
|
|
|
male sex determination
|
GO:0030238 |
14 |
0.026
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.026
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.026
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.026
|
|
|
|
cellular response to vascular endothelial growth factor stimulus
|
GO:0035924 |
11 |
0.026
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.025
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.025
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.025
|
|
|
|
positive regulation of g0 to g1 transition
|
GO:0070318 |
2 |
0.025
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.025
|
|
|
|
negative regulation of protein activation cascade
|
GO:2000258 |
3 |
0.025
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.025
|
|
|
|
myoblast proliferation
|
GO:0051450 |
11 |
0.025
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.025
|
|
|
|
hypothalamic tangential migration using cell axon interactions
|
GO:0021856 |
3 |
0.025
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.025
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.025
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.025
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.025
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.025
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.025
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.025
|
|
|
|
transcription initiation from rna polymerase i promoter
|
GO:0006361 |
4 |
0.025
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.024
|
|
|
|
cell migration involved in kidney development
|
GO:0035787 |
3 |
0.024
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.024
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.024
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.024
|
|
|
|
facioacoustic ganglion development
|
GO:1903375 |
3 |
0.024
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.024
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.024
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.024
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.024
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.024
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.024
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.024
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.024
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.024
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.024
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.024
|
|
|
|
epithelial cell proliferation involved in prostate gland development
|
GO:0060767 |
11 |
0.024
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.024
|
|
|
|
regulation of phospholipid biosynthetic process
|
GO:0071071 |
3 |
0.023
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.023
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.023
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.023
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.023
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.023
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.023
|
|
|
|
negative regulation of oocyte maturation
|
GO:1900194 |
5 |
0.023
|
|
|
|
glial cell proliferation
|
GO:0014009 |
10 |
0.023
|
|
|
|
positive regulation of vasculogenesis
|
GO:2001214 |
7 |
0.023
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.023
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.023
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.023
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.023
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.023
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.023
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.022
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.022
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.022
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.022
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.022
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.022
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.022
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.022
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.022
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.022
|
|
|
|
negative regulation of muscle hypertrophy
|
GO:0014741 |
9 |
0.022
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.022
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.022
|
|
|
|
platelet derived growth factor receptor beta signaling pathway
|
GO:0035791 |
4 |
0.022
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.022
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.022
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.021
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.021
|
|
|
|
inner cell mass cell differentiation
|
GO:0001826 |
7 |
0.021
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.021
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.021
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.021
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.021
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.021
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.021
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.021
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.021
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.021
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.021
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.021
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.021
|
|
|
|
regulation of transcription involved in primary germ layer cell fate commitment
|
GO:0060796 |
2 |
0.020
|
|
|
|
endodermal digestive tract morphogenesis
|
GO:0061031 |
4 |
0.020
|
|
|
|
melanocyte adhesion
|
GO:0097326 |
1 |
0.020
|
|
|
|
mating behavior sex discrimination
|
GO:0048047 |
1 |
0.020
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.020
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.020
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.020
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.020
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.020
|
|
|
|
retinal rod cell differentiation
|
GO:0060221 |
2 |
0.020
|
|
|
|
response to symbiont
|
GO:0009608 |
2 |
0.020
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.020
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.020
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.020
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.020
|
|
|
|
epithelial structure maintenance
|
GO:0010669 |
9 |
0.020
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.020
|
|
|
|
metanephric nephron tubule formation
|
GO:0072289 |
4 |
0.020
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.020
|
|
|
|
positive regulation of extracellular matrix assembly
|
GO:1901203 |
1 |
0.020
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.019
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.019
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.019
|
|
|
|
regulation of retinal ganglion cell axon guidance
|
GO:0090259 |
2 |
0.019
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.019
|
|
|
|
cardioblast migration to the midline involved in heart field formation
|
GO:0060975 |
1 |
0.019
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.019
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.019
|
|
|
|
bronchus cartilage development
|
GO:0060532 |
2 |
0.019
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.019
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.019
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.019
|
|
|
|
lens epithelial cell proliferation
|
GO:0097166 |
1 |
0.019
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.019
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.019
|
|
|
|
closure of optic fissure
|
GO:0061386 |
2 |
0.019
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.019
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.019
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.019
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.019
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.019
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.019
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.019
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.019
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.019
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.019
|
|
|
|
developmental pigmentation
|
GO:0048066 |
40 |
0.018
|
|
|
|
regulation of adrenergic receptor signaling pathway
|
GO:0071877 |
4 |
0.018
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.018
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.018
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase activity
|
GO:0043552 |
11 |
0.018
|
|
|
|
camera type eye photoreceptor cell differentiation
|
GO:0060219 |
15 |
0.018
|
|
|
|
positive regulation of cell proliferation involved in heart morphogenesis
|
GO:2000138 |
5 |
0.018
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.018
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.018
|
|
|
|
negative regulation of b cell differentiation
|
GO:0045578 |
4 |
0.018
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.018
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.018
|
|
|
|
optic cup morphogenesis involved in camera type eye development
|
GO:0002072 |
7 |
0.018
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.018
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.018
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.018
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.018
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.018
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.018
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.017
|
|
|
|
positive regulation of protein import into nucleus
|
GO:0042307 |
26 |
0.017
|
|
|
|
regulation of g protein activated inward rectifier potassium channel activity
|
GO:1900128 |
1 |
0.017
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.017
|
|
|
|
neuron projection extension involved in neuron projection guidance
|
GO:1902284 |
14 |
0.017
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.017
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.017
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.017
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.017
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.017
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.017
|
|
|
|
lymphoid progenitor cell differentiation
|
GO:0002320 |
17 |
0.017
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.017
|
|
|
|
positive regulation of jak stat cascade
|
GO:0046427 |
22 |
0.017
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.017
|
|
|
|
myeloid progenitor cell differentiation
|
GO:0002318 |
8 |
0.017
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.017
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.017
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.017
|
|
|
|
regulation of blood vessel remodeling
|
GO:0060312 |
3 |
0.017
|
|
